Literature DB >> 7462402

Serum immunoreactive somatomedin levels in normal adults, pregnant women at term, children at various ages, and children with constitutionally delayed growth.

R M Bala, J Lopatka, A Leung, E McCoy, R G McArthur.   

Abstract

Immunoreactive somatomedin (IRSM) levels in term pregnancy material sera (MS) and newborn cord sera (CS) were higher and lower, respectively, than those in normal adults. IRSM levels in MS and CS were not correlated, suggesting that SM dose not cross the placenta. The similar levels of IRSM in arterial and venous CS suggest that the placenta does not produce SM. IRSM levels in CS were higher than those in newborn sera and were correlated with day 1 newborn sera, suggesting that the placenta may regulate fetal serum IRSM levels. Serum IRSM levels in normal children gradually increased from birth to peak levels at puberty. The mean levels of serum IRSM reached peak levels 2 yr earlier in females. Males near pubertal age with constitutionally delayed growth had lower serum IRSM levels than age-matched controls. Diagnostic measurements of serum IRSM in children requires comparison with age- and sex-matched controls. Serum SM levels may only approximately reflect the local concentrations or activities of SM in various tissues.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7462402     DOI: 10.1210/jcem-52-3-508

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  Influence of bone and soft-tissue operations on serum concentrations of growth hormone, somatomedin C and alkaline phosphatase.

Authors:  H R Casser; K W Zilkens; R Forst; A Brüggemann
Journal:  Arch Orthop Trauma Surg       Date:  1990       Impact factor: 3.067

2.  Testosterone stimulates growth of tibial epiphyseal growth plate and insulin-like growth factor-1 receptor abundance in hypophysectomized and castrated rats.

Authors:  M Phillip; G Maor; S Assa; A Silbergeld; Y Segev
Journal:  Endocrine       Date:  2001-10       Impact factor: 3.633

Review 3.  Stunted growth with more or less normal appearance.

Authors:  J R Bierich; H Enders; U Heinrich; R Huenges; M B Ranke; D Schoenberg
Journal:  Eur J Pediatr       Date:  1982-12       Impact factor: 3.183

Review 4.  [Principles and clinical significance of insulin-like growth factors/somatomedins].

Authors:  E Weimann; W Kiess
Journal:  Klin Wochenschr       Date:  1990-10-17

5.  Somatomedin-C levels related to gestational age, birth weight and day of life.

Authors:  A Cassio; M Capelli; E Cacciari; A Cicognani; P Pirazzoli; F Righetti; D Ballardini; G Natali; S Zucchini; E Martelli
Journal:  Eur J Pediatr       Date:  1986-08       Impact factor: 3.183

6.  Excessive growth in a child with craniopharyngioma and growth hormone deficiency.

Authors:  J M Wit; A Schuitema-Dijkstra; S van Buul-Offers; F Opmeer; J L Van den Brande
Journal:  Eur J Pediatr       Date:  1988-08       Impact factor: 3.183

7.  Insulin-like growth factors (IGF) I and II in diabetic pregnancy: suppression of normal pregnancy-induced rise of IGF-I.

Authors:  B Bhaumick; A D Danilkewich; R M Bala
Journal:  Diabetologia       Date:  1986-11       Impact factor: 10.122

8.  Radioimmunological determination of insulinlike growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia.

Authors:  J Zapf; H Walter; E R Froesch
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

9.  Size at birth and plasma insulin-like growth factor-1 concentrations.

Authors:  C H Fall; A N Pandit; C M Law; C S Yajnik; P M Clark; B Breier; C Osmond; A W Shiell; P D Gluckman; D J Barker
Journal:  Arch Dis Child       Date:  1995-10       Impact factor: 3.791

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.